Synopsis
Synopsis
0
CEP/COS
0
NDC API
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (-)-(6r,7r)-2,2-dimethylpropionyloxymethyl 7-((z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido)-3-((z)-2-(4-methylthiazol-5-yl)ethenyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
2. 7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(2-(4-methylthiazol-5-yl)ethenyl)cephem-4-carboxylic Acid Pivaloyloxymethyl Ester
3. Cdtr-pi
4. Me 1207
5. Me-1207
6. Spectracef
1. Spectracef
2. 117467-28-4
3. Cefditoren Pivaloyloxymethyl Ester
4. Cdtr-pi
5. Meiact
6. Cefditoren (pivoxil)
7. Cefditoren Pivoxil [jan]
8. Me-1207
9. Cefditorin Pivoxil
10. Me1207
11. Cefditoren Pivoxil Hcl
12. 78tha212dh
13. Cefditorin
14. Chebi:560555
15. Me 1207
16. Nsc-759098
17. 2,2-dimethylpropanoyloxymethyl (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
18. Cefditoren Pi Voxil
19. Cefditoren-pivoxil
20. [(2,2-dimethylpropanoyl)oxy]methyl (6r,7r)-7-{[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
21. [(2,2-dimethylpropanoyl)oxy]methyl 7beta-(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido-3-[(z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-3,4-didehydrocepham-4-carboxylic Acid
22. 1448435-17-3
23. Pivaloyloxymethyl (+)-(6r,7r)-7-{[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
24. Ccris 7768
25. Unii-78tha212dh
26. Spectracef (tn)
27. Ncgc00095175-01
28. Meiact (tn)
29. Mfcd00933166
30. Dsstox_cid_28669
31. Dsstox_rid_82939
32. Dsstox_gsid_48743
33. Schembl182876
34. Chembl454446
35. Cefditoren Pivoxil [usan:jan]
36. Dtxsid2048743
37. Cefditoren Pivoxil [usan]
38. Cefditoren Pivoxil (jp17/usan)
39. Cefditoren Pivoxil [vandf]
40. Cefditoren Pivoxil [mart.]
41. Cefditoren Pivoxil [who-dd]
42. Tox21_113197
43. Hy-17452a
44. S1768
45. Akos025311444
46. Ccg-270254
47. Cs-1949
48. Nsc 759098
49. Cefditoren Pivoxil [orange Book]
50. Ncgc00095175-08
51. (pivaloyloxy)methyl (6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((z)-2-(4-methylthiazol-5-yl)vinyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
52. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-((1z)-2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-,2,2-dimethyl-1-oxopropoxy)methyl Ester, (6r,7r)-
53. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (6r-(3(z),6-alpha,7-beta-(z)))-
54. As-12951
55. B2086
56. Cas-117467-28-4
57. Cefditoren Pivaloyloxymethyl Ester [mi]
58. D01628
59. Ab01274730-01
60. Ab01274730_02
61. 467c284
62. Brd-k72167406-001-03-9
63. (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-((z)-2-(4-methyl-5-thiazolyl)vinyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate Pivaloyloxy Methyl Ester, 7(sup 2)-(z)-(o-methyloxime)
64. (6r,7r)-(pivaloyloxy)methyl 7-((z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((z)-2-(4-methylthiazol-5-yl)vinyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
65. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7(((2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-((1z)-2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (6r,7r)-
Molecular Weight | 620.7 g/mol |
---|---|
Molecular Formula | C25H28N6O7S3 |
XLogP3 | 4.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 12 |
Exact Mass | 620.11816077 g/mol |
Monoisotopic Mass | 620.11816077 g/mol |
Topological Polar Surface Area | 257 Ų |
Heavy Atom Count | 41 |
Formal Charge | 0 |
Complexity | 1160 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Spectracef |
PubMed Health | Cefditoren Pivoxil (By mouth) |
Drug Classes | Antibiotic |
Drug Label | SPECTRACEF tablets contain cefditoren pivoxil, a semi-synthetic cephalosporin antibiotic for oral administration. It is a prodrug which is hydrolyzed by esterases during absorption, and the drug is distributed in the circulating blood as active cef... |
Active Ingredient | Cefditoren pivoxil |
Dosage Form | Tablet |
Route | Oral |
Strength | 200mg; 400mg |
Market Status | Prescription |
Company | Vansen Pharma |
2 of 2 | |
---|---|
Drug Name | Spectracef |
PubMed Health | Cefditoren Pivoxil (By mouth) |
Drug Classes | Antibiotic |
Drug Label | SPECTRACEF tablets contain cefditoren pivoxil, a semi-synthetic cephalosporin antibiotic for oral administration. It is a prodrug which is hydrolyzed by esterases during absorption, and the drug is distributed in the circulating blood as active cef... |
Active Ingredient | Cefditoren pivoxil |
Dosage Form | Tablet |
Route | Oral |
Strength | 200mg; 400mg |
Market Status | Prescription |
Company | Vansen Pharma |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25086
Submission : 2011-06-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20292
Submission : 2007-02-22
Status : Active
Type : II
Date of Issue : 2019-07-22
Valid Till : 2022-07-21
Written Confirmation Number : WC-0131
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17482
Submission : 2004-06-22
Status : Inactive
Type : II
Registration Number : 302MF10072
Registrant's Address : 2-4-16 Kyobashi, Chuo-ku, Tokyo
Initial Date of Registration : 2020-06-26
Latest Date of Registration : --
Registrant Name : Boryeong Co., Ltd.
Registration Date : 2020-11-13
Registration Number : 20201113-209-J-519
Manufacturer Name : Meiji Seika Pharma Co., Ltd.
Manufacturer Address : 2890, Kitagata, Kitagata-cho, Motosu-gun, Gifu-ken, Japan
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19011
Submission : 2005-12-07
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23544
Submission : 2010-04-15
Status : Inactive
Type : II
Date of Issue : 2013-08-08
Valid Till : 2016-07-02
Written Confirmation Number : WC-0224
Address of the Firm :
Registration Number : 219MF10254
Registrant's Address : 343, Sapyeong-daero, Seocho-gu, Seoul, Korea
Initial Date of Registration : 2007-08-06
Latest Date of Registration : --
Registrant Name : Jeil Pharmaceutical Co., Ltd.
Registration Date : 2019-12-19
Registration Number : 20191219-209-J-509
Manufacturer Name : Jeil Pharmaceutical Co., Ltd.
Manufacturer Address : 7, Cheonggang-ga-chang-ro, Baekam-myeon, Cheoin-gu, Yongin-si, Gyeonggi-do (B-dong and others)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23544
Submission : 2010-04-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17482
Submission : 2004-06-22
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20292
Submission : 2007-02-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19011
Submission : 2005-12-07
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25086
Submission : 2011-06-12
Status : Active
Type : II
Registration Number : 219MF10254
Registrant's Address : 343, Sapyeong-daero, Seocho-gu, Seoul, Korea
Initial Date of Registration : 2007-08-06
Latest Date of Registration : 2007-08-06
Registration Number : 302MF10072
Registrant's Address : 2-4-16 Kyobashi, Chuo-ku, Tokyo
Initial Date of Registration : 2020-06-26
Latest Date of Registration : 2020-06-26
Registration Number : 228MF10040
Registrant's Address : 13, Olympic-ro 35da-gil, Songpa-gu, Seoul, Korea
Initial Date of Registration : 2016-02-08
Latest Date of Registration : 2016-02-08
Date of Issue : 2013-08-08
Valid Till : 2016-07-02
Written Confirmation Number : WC-0224
Address of the Firm : 7Km Old Manesar Road Village Mohammedput Gurgoan Haryana
Date of Issue : 2019-07-22
Valid Till : 2022-07-21
Written Confirmation Number : WC-0131
Address of the Firm : Plot Nos. 138-147, SIDCO Industrial Estate, Alathur, Kancheepuram District-603 1...
Registrant Name : KR Pharm Co., Ltd.
Registration Date : 2021-11-18
Registration Number : 20211118-209-J-1153
Manufacturer Name : Covalent Laboratories Pvt Lt...
Manufacturer Address : Sy.No.374, Gundla Machanoor Village, Hathnoor Mandal, Sangareddy District Telangana S...
Registrant Name : Jeil Pharmaceutical Co., Ltd.
Registration Date : 2019-12-19
Registration Number : 20191219-209-J-509
Manufacturer Name : Jeil Pharmaceutical Co., Ltd...
Manufacturer Address : 7, Cheonggang-ga-chang-ro, Baekam-myeon, Cheoin-gu, Yongin-si, Gyeonggi-do (B-dong an...
Registrant Name : Kyungbo Pharmaceutical Co., Ltd.
Registration Date : 2018-10-28
Registration Number : 20181028-209-J-165
Manufacturer Name : Kyungbo Pharmaceutical Co., ...
Manufacturer Address : 174 Silok-ro, Asan-si, Chungcheongnam-do
Registrant Name : Boryeong Co., Ltd.
Registration Date : 2020-11-13
Registration Number : 20201113-209-J-519
Manufacturer Name : Meiji Seika Pharma Co., Ltd.
Manufacturer Address : 2890, Kitagata, Kitagata-cho, Motosu-gun, Gifu-ken, Japan
Registrant Name : Youngjin Pharmaceutical Co., Ltd.
Registration Date : 2019-01-04
Registration Number : 20190104-209-J-293
Manufacturer Name : Youngjin Pharmaceutical Co.,...
Manufacturer Address : 21 Wanju Industrial Complex 5-ro, Bongdong-eup, Wanju-gun, Jeollabuk-do
About the Company : Fuan Pharmaceutical (Group) Co., Ltd. was established on February 25, 2004. The company is located in Chongqing Changshou Economic and Technological Development Zone, covering an a...
About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...
About the Company : Since its foundation in 1959, JEIL Pharm established. its own central research laboratory for the formulation and synthesis of drugs, followed by its successive construction of KGM...
About the Company : Lunan Pharmaceutical Group is an integrated pharmaceutical group setting production, scientific research and sale of traditional Chinese medicines, chemicals, biological products i...
About the Company : Nectar Lifesciences Ltd. (NLL) is a knowledge driven organization which constitutes a vital part of fast growing Indian Pharmaceutical Industry. In a short span of existence, NLL h...
About the Company : Public health is always an imperative that implies immense responsibility, not a mere re-adjustable option. As a company operating under world’s second largest industry of Pharma...
About the Company : Established in 1992 as an export-oriented unit (EOU), Orchid Pharma Ltd. (Orchid) is a vertically integrated company spanning the entire pharmaceutical value chain from discovery t...
About the Company : Located in Jinan, Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. It focuses on developing, manufacturing and marketing of generic drugs and active pha...
About the Company : Suvan Lifesciences, an organization certified with GMP & ISO standards, stands out as a reputable producer and exporter of high-grade Active Pharmaceutical Ingredients. Our sophist...
About the Company : Virchow Group comprises of six active pharmaceutical ingredient (API) and drug intermediate manufacturing units and two biotech units. Incorporated in 1981, the flagship company of...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SPECTRACEF
Dosage Form : TABLET;ORAL
Dosage Strength : 200MG
Packaging :
Approval Date : 2001-08-29
Application Number : 21222
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SPECTRACEF
Dosage Form : TABLET;ORAL
Dosage Strength : 400MG
Packaging :
Approval Date : 2008-07-21
Application Number : 21222
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Generic
Registration Country : India
Brand Name : CEFDITOR
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number : 21222
Regulatory Info : Generic
Registration Country : India
RLD : No
TE Code :
Brand Name : SPECTRACEF
Dosage Form : TABLET;ORAL
Dosage Strength : 200MG
Approval Date : 2001-08-29
Application Number : 21222
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : SPECTRACEF
Dosage Form : TABLET;ORAL
Dosage Strength : 400MG
Approval Date : 2008-07-21
Application Number : 21222
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 200MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name : CEFDITOR
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number : 21222
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 200MG
Brand Name : CEFDITOR
Approval Date :
Application Number : 21222
Registration Country : India
Related Excipient Companies
Dosage Form : Solution
Grade : Oral, Topical
Application : Solubilizers
Excipient Details : Hydrosol 50 is used as a solubilizer and emulsifying agent in oral and topical liquid and semi-solid dosage forms.
Pharmacopoeia Ref : USP/NF
Technical Specs : N/A
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?